Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.

• Authors: Gjin Ndrepepa, Albert Schömig, Adnan Kastrati
• Journal: JAMA (JAMA) Vol. 297 Issue 15 Pg. 1711-3 (Apr 18 2007) ISSN: 1538-3598 [Electronic] United States
• PMID: 17440148 (Publication Type: Comment, Editorial)

Chemical References

• Enzyme Inhibitors
• N(G)-monomethylarginine acetate
• Vasoconstrictor Agents
• Arginine
• Nitric Oxide Synthase

Topics

• Arginine (analogs & derivatives, therapeutic use)
• Enzyme Inhibitors (therapeutic use)
• Humans
• Nitric Oxide Synthase (antagonists & inhibitors)
• Shock, Cardiogenic (drug therapy)
• Vasoconstrictor Agents (therapeutic use)